Read zantriocom's blog in RSS
March 15, 2010
Share ThisMedtronic received word that FDA'S panel of neurological experts voted 7-5 in favor of Medtronic's Deep Brain Stimulation implant. Request is for the FDA to approve its implant for reducing seizures caused by epilepsy.
(G) - short
Genpact Limited appears to have reached a peak on the way higher. Potential stands for pullback ahead of potential gains in upcoming days.
(VR) - short
Validus Holdings provided initial estimate of losses from recent Chilean Earthquake and European Windstorm Xynthia totaling in range of $300M net of reinstatement premiums and reinsurance, retrocessional and other recoveries.
(ENZ) - short
Enzo Biochem Q2 net loss totaled ($10.3) million or ($0.27) PBDS compared with year ago net loss of ($7.7)M or ($0.20) PBDS.
-------
Signup and get instant entry alerts for the Free Daily Stock Picks at Zantrio.com